Article
Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data.
Molecular oncology - 1 Dec 2025
Zhu Rong, Eason Katherine, Chin Suet-Feung, Edwards Paul A W, Manzano Garcia Raquel, Moulange Richard, Pan Jia Wern, Teo Soo Hwang, Mukherjee Sach, Callari Maurizio, Caldas Carlos, Sammut Stephen-John, Rueda Oscar M
Abstract excerpt
Homologous recombination deficiency (HRD) leads to genomic instability, and patients with HRD can benefit from HRD-targeting therapies. Previous studies have primarily focused on identifying HRD biomarkers using data from a single technology. Here we integrated features from different genomic data types, including total copy number (CN), allele-specific copy number (ASCN) and single nucleotide variants (SNV)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
